---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-035515"
form_type: "8-K"
ticker: "PASG"
cik: "0001787297"
company_name: "Passage BIO, Inc."
filed_at: "2026-09-03T01:37:16+00:00"
generated_at: "2026-09-03T10:05:28.141541+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Passage Bio amends Remix merger to two-step structure; $70M financing via pre-funded warrants

## Summary
- Amended merger agreement dated Sept 2, 2026 restructures deal into two-step merger (First Merger then Second Merger) to qualify as tax-free reorganization.
- Concurrent financing of ~$70.0M via Remix shares and/or pre-funded warrants at $1.3861/share and $1.3860/warrant.
- Registration rights extended to shares issuable upon pre-funded warrants; resale registration statement to be filed within 30 days post-closing.
- Boards of both companies approved and recommend the transaction; outside date remains Dec 24, 2026.
- No change to economic terms, equity value, or termination fees from original June 24, 2026 agreement.

## SEC filing metadata
- accession: 0001140361-26-035515
- form_type: 8-K
- ticker: PASG
- cik: 0001787297
- company_name: Passage BIO, Inc.
- filed_at: 2026-09-03T01:37:16+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787297/000114036126035515/0001140361-26-035515-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787297/000114036126035515/ef20081513_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-035515
- JSON: https://secwatch.observer/filing/0001140361-26-035515.json
- Plain text: https://secwatch.observer/filing/0001140361-26-035515.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.